Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPL | P40238 | 12/20 | 1.00 |
| ▸ | CTRC | Q99895 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.74 |
| ▸ | TSHR | P16473 | 2/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.74 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.74 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.70 |
| ▸ | NSD2 | O96028 | 1/20 | 0.69 |
| ▸ | MMP14 | P50281 | 1/20 | 0.69 |
| ▸ | CASP6 | P55212 | 1/20 | 0.69 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.58 |
| ▸ | PTPRA | P18433 | 1/20 | 0.54 |
| ▸ | PTPRB | P23467 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4596970 | 1.00 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL12206631 | 0.90 | MPL (0.81) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL12459388 | 0.88 | MPL (0.78) | MPLCTRCCYP1A2CYP2C9TSHR | |
| Eriochrome Blue Black B SCHEMBL18281602 | 0.88 | MPL (0.78) | MPLCTRCCYP1A2CYP2C9TSHR | |
| Eriochrome Blue Black B SCHEMBL29923948 | 0.88 | MPL (0.78) | MPLCTRCCYP1A2CYP2C9TSHR | |
| Eriochrome Blue Black B SCHEMBL591901 | 0.88 | MPL (0.78) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL7247118 | 0.87 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL30371538 | 0.87 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL29362358 | 0.87 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR | |
| SCHEMBL3010602 | 0.87 | MPL (1.00) | MPLCTRCCYP1A2CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210278381-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | Water Lens, LLC | 2021-09-09 | — | — | US | claimed |
| US-10845346-B2 | Compositions, apparatus, and methods for determining hardness of water and magnesium ion in an analyte composition | Water Lens, LLC (US) | 2020-11-24 | — | — | US | claimed |
| US-20180156763-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | Water Lens, LLC | 2018-06-07 | — | — | US | claimed |
| WO-2016196207-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | WATER LENS, LLC. (US) | 2016-12-08 | — | — | WO | claimed |
| US-6670387-B1 | Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor | SMITHKLINE BEECHAM CORPORATION | 2003-12-30 | — | — | US | claimed |
| US-20250123252-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | Water Lens, LLC | 2025-04-17 | — | — | US | disclosed |
| US-11885783-B2 | Compositions, apparatus, and methods for determining hardness of water and magnesium ion in an analyte composition | Water Lens, LLC (US) | 2024-01-30 | — | — | US | disclosed |
| US-20210278381-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | Water Lens, LLC | 2021-09-09 | — | — | US | disclosed |
| US-20210002329-A1 | STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-01-07 | — | — | US | disclosed |
| US-10845346-B2 | Compositions, apparatus, and methods for determining hardness of water and magnesium ion in an analyte composition | Water Lens, LLC (US) | 2020-11-24 | — | — | US | disclosed |
| US-10815271-B2 | Structure-based peptide inhibitors of alpha-synuclein aggregation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-10-27 | — | — | US | disclosed |
| US-10400010-B2 | Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-09-03 | — | — | US | disclosed |
| US-7531319-B2 | Array for rapid detection of a microorganism | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-05-12 | — | — | US | disclosed |
| US-20090111088-A1 | RAPID ASSESSMENT OF UPPER RESPIRATORY CONDITIONS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-04-30 | — | — | US | disclosed |
| US-20080145316-A1 | Skin coating with microbial indicator | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080057532-A1 | Method for detecting Candida on skin | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-03-06 | — | — | US | disclosed |
| US-20080057533-A1 | Array for rapid detection of a microorganism | KIMBERLY-CLARK WORLDWIDE, INC. | 2008-03-06 | — | — | US | disclosed |
| EP-1351979-B1 | REGULATED ACTIVATION OF CELL-MEMBRANE RECEPTORS BY METAL-CHELATING AGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20040053299-A1 | Regulated activation of cell-membrane receptors by metal-chelating agonists | SMITHKLINE BEECHAM CORPORATION | 2004-03-18 | — | — | US | disclosed |
| US-6670387-B1 | Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor | SMITHKLINE BEECHAM CORPORATION | 2003-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053299-A1 | Regulated activation of cell-membrane receptors by metal-chelating agonists | CASR, TRPM8, TRPM6 | MPL 349/4885CTRC 2199/4885CYP1A2 4794/4885 |
| US-20210002329-A1 | STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION | SNCA, PARK7, IAPP | MPL 3787/4885CTRC 353/4885CYP1A2 4876/4885 |
| US-10815271-B2 | Structure-based peptide inhibitors of alpha-synuclein aggregation | SNCA, PARK7, IAPP | MPL 3787/4885CTRC 353/4885CYP1A2 4876/4885 |
| US-20080145316-A1 | Skin coating with microbial indicator | CUTA, S100A8, STING1 | MPL 861/4885CTRC 483/4885CYP1A2 1657/4885 |
| US-10400010-B2 | Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics | TP53, TP53BP1, API5 | MPL 4700/4885CTRC 436/4885CYP1A2 4856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.